Assistant Research Professor
Institute of molecular genetics and genetic engineering (IMGGE),
University of Belgrade
Vojvode Stepe 444a, 11042 Belgrade 152, Serbia
Mobile: +381 65 397 66 58
Phone: +381 11 397 66 58
Fax: +381 11 397 58 08
E-mail: mirjananovkovic@imgge.bg.ac.rs
EDUCATION
2018 - PhD, Faculty of Biology (FB), University of Belgrade
2012 - PhD student of Molecular biology of eukaryotes, Faculty of Biology (FB), University of Belgrade
2012 - Degree in biology, Faculty of Biology (FB), University of Belgrade (UB)
RESEARCH EXPERIENCE
2017 - Research Assistant, Laboratory for Molecular Biology, IMGGE
2015 - Research Trainee, Laboratory for Molecular Biology, IMGGE
2012 - PhD student, Laboratory for Molecular Biology, IMGGE
2011 - 2012 - research volonteer in Center for Human Molecular Genetics at Faculty of Biology
RESEARCH INTEREST
- Biomarkers for human diseases.
- Molecular genetics.
- DNA analysis and molecular diagnostics.
- Pharmacogenetics in cardiovascular diseases.
- Regulation and expression of CYP2C9 and CYP2C19 genes.
- Epigenetic regulation of gene expresion.
SELECTED PUBLICATIONS
- Novkovic M, Matic D, Kusic-Tisma J, Antonijevic N, Radojkovic D, Rakicevic L (2018) Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel. Eur J Clin Pharmacol 74 (4): 443-451 DOI 10.1007/s00228-017-2401-5
- Mitropoulou C, Fragoulakis V, Rakicevic LB, Novkovic MM, Vozikis A, Matic DM, Antonijevic NM, Radojkovic DP, van Schaik RH, Patrinos GP (2016) Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention. Pharmacogenomics DOI 10.2217/pgs-2016-0052
- Backovic D, Ignjatovic S, Rakicevic L, Novkovic M, Kusic-Tisma J, Radojkovic D, Strugarevic E, Calija B, Radak D, Kovac M (2016) Clopidogrel High On-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy. A Pilot Study. Curr Vasc Pharmacol 14 (6): 563-569